Acta Interna - The Journal of Internal Medicine
13. James F., Ching LL, David B., Danny W., Tin-Kin C., Man-Fung Y. 2008. Fibrosis and prevalence of cirrhosis in Chronic Hepatitis B: Implication for Treatment and Management. American J of Gastroenterology. 103 (6): 1421-1426
14. Blankson, A., Wiredu, EK, Gyasi, RK-, Adjei, A., Tettey, Y. 2005. Sero-prevalence of Hepatitis B and C viruses in cirrhosis of the liver in Accra-Ghana. Ghana Med J. 39 (4): 132 -137
15. Rainer, P., Woitas,, Birgit, SW 2000. Correlation of Serum Concentration of cystatin C and creatinine to inulin Clearance in Liver cirrhosis. Clinical Chemistry. 46: 712-715
16. Takeuchi, M., Fukuda, Y., Nakano, I., Katano, Y., Hayakawa, T. 2001. Elevation of serum cystatin in Patients with chronic liver disease. Eur J Gastroenterol Hepatol. 13(8) :951-5
17. Christopher, C., Armelle, PR, Dominique, W., Marie, G., Yves, C., Renee, EP, Robert, P. 2004. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated Patients with primary biliary chirrosis. Liver International. 24(3): 341-344
18. Blake, JC, Sprengers, Grech P., McCormick, PA, McIntyre, N., Burroughs, AK 1990. Bleeding time in Patients with hepatic cirrhosis. British Medical J. 301: 120-125
20
